The Birmingham bone-anchored hearing aid (BAHA) programme has fitted more than 300 patients with unilateral bone-anchored hearing aids since 1988. Some of the patients who benefited well with unilateral aids and who had used bilateral conventional aids previously applied for bilateral amplification. To date, 15 patients have been fitted with bilateral BAHAs. The benefits of bilateral amplification have been compared to unilateral amplification in 11 of these patients. Subjective analysis in the form of validated comprehensive questionnaires was undertaken. The Glasgow benefit inventory (GBI), which is a subjective patient orientated post-interventional questionnaire developed to evaluate any otorhinolaryngological surgery and therapy was administered. The results revealed that the use of bilateral bone-anchored hearing aids significantly enhanced general well being (patient benefit) and improved the patient's state of health (quality of life). The Chung and Stephens questionnaire which addresses specific issues related to binaural hearing was used. Our preliminary results are encouraging and are comparable to the experience of the Nijmegen BAHA group.
Download full-text PDF |
Source |
---|
J Otol
October 2024
Department of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Beijing, China.
The prevalence of unilateral deafness (SSD) or asymmetric hearing loss (AHL) among patients with hearing impairments ranges from 7.2% to 15.0%, indicating a relatively significant proportion.
View Article and Find Full Text PDFCureus
November 2024
Otolaryngology- Head and Neck Surgery, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Objectives: Implantable bone conduction hearing devices offer excellent auditory rehabilitation. Transcutaneous devices, which use an implanted magnet, are gaining popularity due to higher skin complications associated with traditional percutaneous devices. The Cochlear Baha® Attract System (Cochlear Corporation, Sydney, Australia) is a transcutaneous device and is regarded as a passive transcutaneous implant.
View Article and Find Full Text PDFAm J Otolaryngol
December 2024
Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia. Electronic address:
Objective: To describe the use of the TISA (Transcutaneous Implant Skin Anomalies) scale by members of the Colombian Association of Otology (ACON) in the evaluation of patients using bone conduction implants.
Methods: A cross-sectional descriptive observational study was conducted among the members of the Colombian Association of Otology. A voluntary survey was performed, where participants evaluated images of patients with transcutaneous bone conduction implants exhibiting different skin conditions.
Otol Neurotol
January 2025
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.
Sci Rep
December 2024
Department of Neurosciences, Research Group Experimental Oto-rhino-laryngology, KU Leuven, Leuven, B3000, Belgium.
Bone conduction implants enable patients to hear via vibrations transmitted to the skull. The main constraint of current bone conduction implants is their maximum output force level. Stimulating closer to the cochlea is hypothesized to increase efficiency and improve force transfer, addressing this limitation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!